Phase 1 High Risk Neuroblastoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Solid Tumor CancerHigh Risk NeuroblastomaMedulloblastoma

Fundación de investigación HM25 enrolled1 locationNCT06607692

Recruiting

Phase 1

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

SarcomaSCLCMalignant Melanoma+1 more

Y-mAbs Therapeutics60 enrolled8 locationsNCT05130255